BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

  March 4, 2026

   · 

  1 min read
• Press Releases

  Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas

  March 4, 2026

   · 

  3 min read
• Press Releases

  Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting

  March 4, 2026

   · 

  3 min read
• Press Releases

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 3, 2026

  March 4, 2026

   · 

  2 min read
• Press Releases

  Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function

  March 4, 2026

   · 

  6 min read
• Press Releases

  Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

  March 4, 2026

   · 

  1 min read
• Press Releases

  Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

  March 4, 2026

   · 

  6 min read
• Press Releases

  Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

  March 4, 2026

   · 

  4 min read
• Press Releases

  BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy

  March 4, 2026

   · 

  6 min read
• Press Releases

  Independent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy

  March 4, 2026

   · 

  5 min read